Clinical Trials Browser

Phase 1/2 × Central Nervous System Neoplasms × entinostat × Clear all

NCT03838042 2024-02-07

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies

Phase 1/2 Recruiting

Central Nervous System Neoplasms